Compare Modine Manufacturing Company (MOD) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Modine Manufacturing Company vs TG Therapeutics Inc — how do they compare? Modine Manufacturing Company trades at $202.06 (market cap $10.53B), while TG Therapeutics Inc trades at $49.7 (market cap $7.64B). The key difference: Modine Manufacturing Company is the larger of the two by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Modine Manufacturing Company nearer its low. Which is the better fit depends on your goals.
| MOD | TGTX | |
|---|---|---|
Market Cap | $10.53B | $7.64B |
Sector | Technology | Health |
52-Week High | $306.89 | $59.06 |
52-Week Low | $119.68 | $26.94 |
Enterprise Value | $10.97B | $7.84B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
